Correction: Zsengellér et al. Mitigating Oxidative Stress and Anti-Angiogenic State in an In Vitro Model of Preeclampsia by HY-12, an Organofluorine Hydrazone Antioxidant. Curr. Issues Mol. Biol. 2025, 47, 680

Zsuzsanna K. Zsengellér; Maxim Mastyugin; Adrianna R. Fusco; Bernadett Vlocskó; Maximilian Costa; Coryn Ferguson; Diana Pintye; Réka Eszter Sziva; Saira Salahuddin; Brett C. Young; Marianna Török; Béla Török

doi:10.3390/cimb48030301

March 11, 2026Current Issues in Molecular BiologyOpen Access

Correction: Zsengellér et al. Mitigating Oxidative Stress and Anti-Angiogenic State in an In Vitro Model of Preeclampsia by HY-12, an Organofluorine Hydrazone Antioxidant. Curr. Issues Mol. Biol. 2025, 47, 680

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to assess the effects of the organofluorine hydrazone antioxidant HY-12 on oxidative stress and angiogenesis related to preeclampsia.
Developed an in vitro model of preeclampsia.
Administered HY-12 to assess its effects.
Measured markers of oxidative stress and angiogenesis.
HY-12 significantly reduced oxidative stress markers.
Improvements in angiogenic activity were observed.
Suggests therapeutic potential for managing preeclampsia.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Correction reports mitigation of oxidative stress and angiogenesis in an in vitro model of preeclampsia, suggesting potential therapeutic benefits of HY-12.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zsengellér et al. (2026) studied this question.

synapsesocial.com/papers/69b4fc33b39f7826a300cd92 https://doi.org/10.3390/cimb48030301

View Full Paper

Ask AI

Bookmark

Share

Correction: Zsengellér et al. Mitigating Oxidative Stress and Anti-Angiogenic State in an In Vitro Model of Preeclampsia by HY-12, an Organofluorine Hydrazone Antioxidant. Curr. Issues Mol. Biol. 2025, 47, 680

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Correction: Zsengellér et al. Mitigating Oxidative Stress and Anti-Angiogenic State in an In Vitro Model of Preeclampsia by HY-12, an Organofluorine Hydrazone Antioxidant. Curr. Issues Mol. Biol. 2025, 47, 680

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Keep reading

More related papers

More from Current Issues in Molecular Biology

Keep reading

More related papers

More from Current Issues in Molecular Biology